Predicting Ventricular Tachyarrhythmias Following Acute ST Elevation Myocardial Infarction
PREDICT-VT
1 other identifier
observational
400
1 country
1
Brief Summary
Predict-VT is an investigator-initiated, prospective, observational clinical trial. Four hundred patients with ST elevation acute myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI) will be included. The primary end point is a composite of ventricular tachyarrhythmia (VTA) and sudden cardiac death (SCD). VTAs will be recorded using continuous electrocardiographic (ECG) monitoring in the coronary unit for the first 72 hours, standard ECG and ECG holter monitoring. For the analysis of myocardial function, conventional 2D echocardiography and tissue doppler will be used. For the evaluation of myocardial mechanics, 2D speckle tracking, strain, strain rate and mechanical dispersion will be obtained. Important clinical, laboratory and angiographic variables will also be examined. Patients will be followed-up at 40 days and 1 year. The optimal VTA prediction model will be constructed using logistic regression and bootstrap models. Patients who experience primary end point should undergo secondary SCD prevention using implantable cardioverter defibrillator (ICD). Patients with left ventricular ejection fraction (LVEF) \< 35%, 40 days post acute myocardial infarction (AMI), will be candidates for primary SCD prevention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 9, 2017
CompletedFirst Submitted
Initial submission to the registry
August 21, 2017
CompletedFirst Posted
Study publicly available on registry
August 28, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 14, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2023
CompletedFebruary 10, 2023
February 1, 2023
5.8 years
August 21, 2017
February 7, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Composite of ventricular tachyarrhythmias and sudden cardiac death
Analysis of independent predictors of ventricular tachyarrhythmias and sudden cardiac death in a period of 3-40 days following STEMI. Predictors will be identified from clinical, laboratory, echocardiographic, angiographic and procedural variables collected in the study database, using statistical methods of univariable logistic regression and Cox proportional hazard model. Statistical methods of multivariable logistic regression, bootstrapping and receiver operating characteristic curve analysis will be used for the identification of independent predictors of outcome.
3-40 days after STEMI
Interventions
For the analysis of myocardial function, conventional 2D echocardiography and tissue doppler will be used. For the evaluation of myocardial mechanics, 2D speckle tracking, strain, strain rate and mechanical dispersion will be obtained.
Eligibility Criteria
The study will include 600 patients with acute myocardial infarction (AMI) with ST elevation (STEMI) who are eligible for treatment with primary percutaneous coronary intervention (PPCI) within 12 hours from the onset of symptoms.
You may qualify if:
- years and older
- willing consent in writing
- undergoing primary PCI for STEMI
You may not qualify if:
- cardiogenic shock at admission,
- noncardiac conditions that could interfere with compliance with the protocol,
- coexisting conditions associated with a limited life expectancy in the follow-up period.
- Prior documented arrhythmias like atrial fibrillation or ventricular tachyarrhythmias,
- Permanent pacemaker implanted,
- Previous haemodynamically significant valvular abnormalities,
- Chest wall deformities disabling adequate echocardiographic examination.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinical Centre of Serbia, Emergency Hospital
Belgrade, 11000, Serbia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Igor Mrdovic
Clinical Centre of Serbia
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 21, 2017
First Posted
August 28, 2017
Study Start
January 9, 2017
Primary Completion
October 14, 2022
Study Completion
February 1, 2023
Last Updated
February 10, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share